[1] Polaris Observatory Collaborators.Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study[J]. Lancet Gastroenterol Hepatol, 2018, 3(6):383-403. [2] 姜慧芬,陈卓,方任华,等.我国2004—2012年乙型病毒性肝炎疫情分析[J].中国卫生检验杂志, 2015,25(3):408-411. [3] 董博,胡海石,王德景,等.慢性乙型肝炎病毒感染患者血清HBV-LP水平与HBV-DNA及HBeAg的关系及临床意义[J].实用预防医学,2019,26(4):490-492. [4] 王冰琼,孙亚朦,尤红, 等. 肝纤维化逆转的病理评估[J]. 临床肝胆病杂志, 2017, 33(3):435-437. [5] Coskun M. Hepatocellular carcinoma in the cirrhotic liver:evaluation using computed tomography and magnetic resonance imaging[J]. Exp Clin Transplant, 2017, 15(Suppl 2):36-44. [6] 张良东, 刘杰, 任晓娟, 等. 正常肝脏与乙型肝炎肝硬化及乙型肝炎病毒相关性肝癌组织中 mi RNA 表达谱差异[J].中华医院感染学杂志, 2016, 26(4):749-751. [7] Song Y, Wang F, Huang Q, et al. MicroRNAs contribute to hepatocellular carcinoma[J]. Mini Rev Med Chem, 2015, 15(6):459-466. [8] Kang L, Mao J, Tao YJ, et al. MicroRNA-34a suppresses the breast cancer stem cell-like characteristics by downregulating Notch1 pathway[J]. Cancer Sci, 2015, 106(6):700-708. [9] Adams BD, Parsons C, Slack FJ. The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas[J]. Expert Opin Ther Targets, 2016, 20(6):737-753. [10] 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2015更新版)[J]. 肝脏, 2015,26(12):915-932. [11] Scheuer PJ. The nomenclature of chronic hepatitis:time for a change[J]. J Hepatol.1995, 22(1):112-114. [12] Lambrecht J, Jan Poortmans P, Verhulst S, et al. Circulating ECV-associated mi RNAs as potential clinical biomarkers in early stage HBV and HCV induced liver fibrosis[J]. Front Pharmacol, 2017,8:56. [13] Appourchaux K, Dokmak S, Resche-Rigon M, et al. MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C[J]. Sci Rep, 2016, 6:34935. [14] 张清清. 血清(血浆)mi RNA 对慢性乙型肝炎肝纤维化非创伤性诊断价值的临床研究[D]. 上海:上海交通大学, 2015. [15] Chen R, Wu JC, Liu T, et al. Micro RNA profile analysis in the liver fibrotic tissues of chronic hepatitis B patients[J]. J Dig Dis, 2017,18(2):115-124. [16] Komabayashi Y, Kishibe K, Nagato T, et al. Circulating Epstein-Barr virus-encoded micro-RNAs as potential biomarkers for nasal natural killer/T-cell lymphoma[J]. Hematol Oncol, 2017, 35(4):655-663. [17] 李萍英, 杨永耿, 陆伦根, 等. micro RNA 在慢性乙型肝炎肝纤维化中的诊断价值[J]. 临床肝胆病杂志, 2017, 33(12):2412-2415. [18] Huang Y, Yan Y, Xv W, et al. A new insight into the roles of MiRNAs in metabolic syndrome[J]. Biomed Res Int, 2018,2018:1-15. [19] Murakami Y, Yasuda T, Saigo K, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues[J]. Oncogene, 2006, 25(17):2537-2545.
2020, Vol. 27 
